FTC official: policy steady even as drug prices spike
While sharp rises in generic and branded drug prices in recent years have led to increased attention from Congress and consumers, a Federal Trade Commission lawyer said the agency has kept policy steady.
Subscribe to Global Competition Review
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the Global Competition Review experts.
Already have access? Login below
Copyright © Law Business ResearchCompany Number: 03281866 VAT: GB 160 7529 10